152 related articles for article (PubMed ID: 33655565)
1. The Precise Relationship Between Model for End-Stage Liver Disease and Survival Without a Liver Transplant.
VanDerwerken DN; Wood NL; Segev DL; Gentry SE
Hepatology; 2021 Aug; 74(2):950-960. PubMed ID: 33655565
[TBL] [Abstract][Full Text] [Related]
2. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
3. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
[TBL] [Abstract][Full Text] [Related]
4. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
Safwan M; Nwagu U; Collins K; Abouljoud M; Nagai S
Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
[TBL] [Abstract][Full Text] [Related]
5. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.
Sharma P; Schaubel DE; Gong Q; Guidinger M; Merion RM
Hepatology; 2012 Jan; 55(1):192-8. PubMed ID: 21898487
[TBL] [Abstract][Full Text] [Related]
6. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
[TBL] [Abstract][Full Text] [Related]
7. Defining a Liver Transplant Benefit Threshold for the Model for End-Stage Liver Disease-Sodium Score.
Beal EW; Akateh C; Tumin D; Bagante F; Black SM; Washburn K; Azouley D; Pawlik TM
Exp Clin Transplant; 2020 Aug; 18(4):491-497. PubMed ID: 31050611
[TBL] [Abstract][Full Text] [Related]
8. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
Ahn J; Bhuket T; Mosadeghi S; Frenette C; Liu B; Wong RJ
Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
[TBL] [Abstract][Full Text] [Related]
9. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
[TBL] [Abstract][Full Text] [Related]
10. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
11. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
[TBL] [Abstract][Full Text] [Related]
12. MELD-XI Score and Coronary Artery Disease Prevalence and Extent Among In-Hospital Patients With End-Stage Liver Failure Awaiting Transplant.
Keskin S; Çiftci O; Moray G; Müderrisoğlu H; Haberal M
Exp Clin Transplant; 2020 Jan; 18(Suppl 1):88-92. PubMed ID: 32008505
[TBL] [Abstract][Full Text] [Related]
13. Outcomes After Declining a Steatotic Donor Liver for Liver Transplant Candidates in the United States.
Jackson KR; Bowring MG; Holscher C; Haugen CE; Long JJ; Liyanage L; Massie AB; Ottmann S; Philosophe B; Cameron AM; Segev DL; Garonzik-Wang J
Transplantation; 2020 Aug; 104(8):1612-1618. PubMed ID: 32732838
[TBL] [Abstract][Full Text] [Related]
14. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM
Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
[TBL] [Abstract][Full Text] [Related]
15. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End-Stage Liver Disease Scores and Exception Statuses.
Wey A; Noreen S; Gentry S; Cafarella M; Trotter J; Salkowski N; Segev D; Israni A; Kasiske B; Hirose R; Snyder J
Liver Transpl; 2022 Mar; 28(3):363-375. PubMed ID: 34482614
[TBL] [Abstract][Full Text] [Related]
17. HCC patients suffer less from geographic differences in organ availability.
Schuetz C; Dong N; Smoot E; Elias N; Schoenfeld DA; Markmann JF; Yeh H
Am J Transplant; 2013 Nov; 13(11):2989-95. PubMed ID: 24011291
[TBL] [Abstract][Full Text] [Related]
18. Refitting the Model for End-Stage Liver Disease for the Eurotransplant Region.
Goudsmit BFJ; Putter H; Tushuizen ME; Vogelaar S; Pirenne J; Alwayn IPJ; van Hoek B; Braat AE
Hepatology; 2021 Jul; 74(1):351-363. PubMed ID: 33301607
[TBL] [Abstract][Full Text] [Related]
19. Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
Raza MH; Kwon Y; Kobierski P; Misra AC; Lim A; Goldbeck C; Etesami K; Kohli R; Emamaullee J
Liver Transpl; 2023 Feb; 29(2):134-144. PubMed ID: 35876731
[TBL] [Abstract][Full Text] [Related]
20. Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
Yi Z; Mayorga ME; Orman ES; Wheeler SB; Hayashi PH; Barritt AS
Transplantation; 2017 Oct; 101(10):2368-2374. PubMed ID: 28858174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
